Orange Book product · Generic (ANDA)
SODIUM BICARBONATE
SODIUM BICARBONATE
At a glance
Aug 25, 2025
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 25, 2025
10 mo ago
Today
Pharmaceutical detail
Active ingredient
SODIUM BICARBONATE
Strength
2.5MEQ/5ML (0.5MEQ/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 206688
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SODIUM BICARBONATE
- 1986SODIUM BICARBONATE IN PLASTIC CONTAINERBrand (NDA)
NDA 019443 · ABBOTT
- 2026SODIUM BICARBONATEGeneric (ANDA)
ANDA 220788 · ASPIRO
- 2026SODIUM BICARBONATEGeneric (ANDA)
ANDA 217523 · AMNEAL
- 2025SODIUM BICARBONATEGeneric (ANDA)
ANDA 219701 · ANTHEA PHARMA
- 2024SODIUM BICARBONATEGeneric (ANDA)
ANDA 216042 · LONG GROVE PHARMS
- 2023SODIUM BICARBONATEGeneric (ANDA)
ANDA 217594 · STERISCIENCE
- 2023SODIUM BICARBONATEGeneric (ANDA)
ANDA 216364 · OMNIVIUM PHARMS
- 2019SODIUM BICARBONATEGeneric (ANDA)
ANDA 211091 · EXELA PHARMA
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 202432 · HOSPIRA
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 203449 · INTL MEDICATION SYS
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 202679 · HOSPIRA
- 2017SODIUM BICARBONATEGeneric (ANDA)
ANDA 202495 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
